Deaths From Swine Flu Vaccine Reported In EuropeVaccine manufacturer attributes high rate of side effects to novel adjuvants
Oct. 25, 2009
Cannon Hinnant, RIP: 5-Year-Old Boy 'Executed Point Blank' by Criminal Thug While Playing Outside
Latrell Allen: Meet The 20-Yr-Old Gangbanger Whose 'Shootout With Police' Triggered Mass Looting In Chicago
Reopening Gay Bathhouses Will Aid 'Economic And Cultural Recovery,' San Francisco Supervisor Says
Narrative Collapse: Media's Lies About George Floyd's Death Backfire After Video Leaked
Antifa End Up Getting Pummeled In A Ditch After Fight Breaks Out At 'Back The Blue' Rally In Colorado
As European governments forge ahead with mass swine flu vaccination programs, reports out of Hungary and Sweden suggest that some people have died shortly after taking the H1N1 vaccine.
The Budapest Times is reporting that a 64-year-old woman has died just two days after receiving the H1N1 shot.
An autopsy has been scheduled to determine if there is a link between the vaccine and the death of the patient, who suffered from chronic, but mild, heart disease, according to the article.
So far just 4 people have died from swine flu in Hungary.
The country’s H1N1 vaccine is being supplied by local vaccine manufacturer Omninvest. The government there has ordered six million doses cover about 60% of Hungary’s population of 10 million.
Omnivest’s vaccines are egg grown and adjuvanted with aluminum phosphate. The company says that only one dose of their H1N1 vaccine is required. Though they have conducted limited trials with the H1N1 virus, their vaccine, is based on tests with the avian flu strain.
According to the Budapest Times report, Omnivest has threatened to sue over allegations that its swine flu vaccine may be dangerous. However, a leading advisor to the Health Ministry in Hungary, last week suggested that the vaccine is not suitable for small children and pregnant women, in spite of the fact that the shot is being offered to free of charge to those “at risk” groups.
Reports are also emerging out of Sweden that suggest more deaths have occurred.
According to the Swedish newspaper Aftonbladet, medical experts have said that a man in his fifties died of a suspected heart attack 12 hours after receiving the Pandemrix shot, which is manufactured by GlaxoSmithKline.
The newspaper also reported that a 65-year-old women died two days after receiving the jab, she is reported to have suffered from a “muscle condition”.
Here is a rough translation of the article via Google translator:
Flu vaccine may be too strongOther reports out of Sweden suggest that 190 people, including many nurses have reported suffering side effects from the vaccine to the medical authority (MPA).
“So far, the authority has received more than 190 reports from both health care and private individuals. By far the most common are pain in the arm. Then mild flu symptoms like fever, muscle pain, stomach pain, headaches, dizziness and fatigue.” reports Swedish news website DN.se.
The report goes on to state that GlaxoSmithKline is attributing a higher than normal rate of side effects to the adjuvants in the vaccine:
“According to vaccine manufacturer GlaxoSmithKline may be about one in ten vaccinated trouble, which is slightly more than the usual seasonal influenza vaccine. This is because a substance in the vaccine that triggers immune response in time.” the translation reads.
GlaxoSmithKline's Pandemrix vaccine contains the adjuvant squalene.
Vaccinations began throughout Europe a little over a week ago. Sweden was one of the first countries to begin vaccination on October 12.
According to the Stockholm-based European Centre for Disease Prevention and Control, there have been a total of 230 deaths linked to H1N1 in Europe since April, with around 50% of those occurring in the UK.